John Ruckdeschel M.D.
- Barbara Ann Karmanos Cancer Institute
Graduating from Rensselaer Polytechnic Institute with his Bachelors of Science in 1967 John Ruckdeschel then continued his education and received his Medical Degree from Albany Medical School in 1971. He then interned at John Hopkins, took a position at Baltimore Cancer Research Center, and completed his residency at Harvard’s Beth Israel Hospital. After his residency was complete Dr. Ruckdeschel returned to Albany Medical College as a faculty member and continued his work there for fifteen years, ultimately becoming the chief of the division of Medical Oncology. While there he directed the Joint Center for Cancer and Blood Disorders from 1989 to 1991. After fifteen years at Albany Medical College, Ruckdeschel took the position of Chief Executive Officer of the H. Lee Moffit Cancer Center and Research Institute in Tampa, Florida. His training in two ACPE Physician in Management courses allowed him to become a successful CEO at the H. Lee Moffit Cancer Center and Research Institute. There he developed his unique system of management which takes a team approach to cancer treatment and allows him to continue his practice on patients. Therefore, he is able to continue to see patients and create a team of ‘hyper-experts’ that can help patients with cancer. Currently, Dr. Ruckdeschel is the President and CEO of the Barbara Ann Karmanos Cancer Institute and Cancer Foundation in Detroit, Michigan. The Barbara Ann Karmanos Cancer Institute is one of three top mesothelioma treatment centers in the country and recently, in 2004, Dr. Ruckdeschel and the institute launched a clinical investigation to find any correlation between asbestos-related cancers and contaminated Vermiculite, a mineral used in insulation. He also recently signed an affiliation agreement that unites the Barbara Ann Karmanos Cancer Institute and the Metropolitan Florence Nightingale Hospital and Cancer Center in Istanbul, Turkey for international collaboration. This affiliation will provide more resources to the physicians and patients in Turkey and allow for collaboration on cancer research between the two groups.
Dr. Ruckdeschel’s clinical and research interests revolve around lung cancer, biopsychosocial processes and treatment decisions making, and the effects of physician communication on patient accrual. His unconventional doctoring style allows him to understand and connect to patients’ biopsychosocial processes and thus connects him to patients, which help him create better treatment options and help with treatment decision making. He has been given numerous awards and honors and is continuously funded by the National Cancer Institute for his research on effects of physician communication on patients and psychosocial aspects of cancer treatment decision making.
- Barbara Anna Karmanos Cancer Institute. Physician Profile.
Last modified: December 24, 2010.